TIGIT and hepatocellular carcinoma: Our results displayed that the immune checkpoints including PD-L1, PD1, TIGIT, TIM3, and CTLA4 were significantly highly expressed in the high CRFCS group compared with the low CRFCS group in both TCGA and ICGC HCC cohorts (Figures 6C, D).